Science Pool

iPSC-Derived Natural Killer Cells as the Front-Runner Program of the EVOcells Oncology Platform: From Inception to Translational Validation Using Patient Samples

In this poster we focus on:

  • Development of robust feeder-free 3D differentiation protocol to reduce iNK cells
  • Transnational validation of iNK functionality with freshly isolated CLL patient tumor cells
  • Enhances CLL patient tumor cell killing with CAR19 iNK
  • EVOcells Oncology programs